• Breast cancer in ethic minority populations
• Treatment of AIDS malignancies
• Palliative care of AIDS patients

• Multidisciplinary Hematology/Oncology Clinics
• Clinical trials with experimental agents
• University of Colorado Cancer Center affiliation

• Myers AM, Havranek E: Myocardial infarction occurring three years after mantle irradiation for stage IIA Hodgkin’s disease in a 32-year-old women with severe hypercholesterolemia (Type IIA Hyperlipidemia). American Journal of Hematology, 57 (2) February 1998.

• Tupule A, Yung RC, Wernz J, Byron M, Espina, Myers AM, Scadden DT, Cabriales S, IIaw M. Phase II Trial of Liposomal Daunorubicin in the Treatment of AIDS-Related Pulmonary Kaposi’s Sarcoma. J of Clinical Oncology, Vol 16, No 10, 3369-3374, October 1998.

• Banda NK, Simon GR, Sipple J, Terrell K, Archer P, Shpall EJ, Akkina RD, Myers AM, Harrison GS: Depletion of CD34⁺CD4⁺ Cells in Bone Marrow from HIV-I Infected. Biology of Blood and Marrow Transplantation, 5(3): 162-172; 1999.

• Heimbach JK, Biffl WL, Mitchell EL, Finlayson A, Schwartber DS, Myers AM, et al: Breast Conservation Surgery in Affiliated County, University and Private Hospitals. American Journal of Surgery, 178(6):466-9, 1999.

• Simon GR, Myers, AM: Kaposi’s Sarcoma. In: Wood ME, editor. Hematology/Oncology Secrets. 2^nd edition. Hanley & Belfus, Inc.; 1999: 371-375

• Simon GR, Kane MA, Myers AM: Hematologic Abnormalities in HIV Infection. In Wood ME, editor. Hematology/Oncology Secrets. 2^nd edition. Hanley & Belfus, Inc.; 1999: 375-380.

Improvements in outcome of cancer treatments can only come from testing new strategies and agents in precisely defined patients who are objectively monitored. Development of and participation in clinical trials, especially for patients with AIDS malignancies, is a major focus.

  To top of page